Your browser doesn't support javascript.
loading
Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection.
Delitto, Daniel; Zabransky, Daniel J; Chen, Fangluo; Thompson, Elizabeth D; Zimmerman, Jacquelyn W; Armstrong, Todd D; Leatherman, James M; Suri, Reecha; Lopez-Vidal, Tamara Y; Huff, Amanda L; Lyman, Melissa R; Guinn, Samantha R; Baretti, Marina; Kagohara, Luciane T; Ho, Won Jin; Azad, Nilofer S; Burns, William R; He, Jin; Wolfgang, Christopher L; Burkhart, Richard A; Zheng, Lei; Yarchoan, Mark; Zaidi, Neeha; Jaffee, Elizabeth M.
  • Delitto D; Department of Surgery, Stanford University School of Medicine, Stanford, USA.
  • Zabransky DJ; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Chen F; The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Thompson ED; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Zimmerman JW; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Armstrong TD; The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Leatherman JM; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Suri R; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Lopez-Vidal TY; The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Huff AL; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Lyman MR; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Guinn SR; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Baretti M; The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Kagohara LT; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Ho WJ; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Azad NS; The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Burns WR; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care, Johns Hopkins University School of Medicine, Baltimore, USA.
  • He J; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Wolfgang CL; The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Burkhart RA; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Zheng L; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Yarchoan M; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Zaidi N; The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Jaffee EM; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care, Johns Hopkins University School of Medicine, Baltimore, USA.
Oncoimmunology ; 10(1): 2001159, 2021.
Article en En | MEDLINE | ID: mdl-34777919

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Vacunas contra el Cáncer Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Vacunas contra el Cáncer Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article